Nephrosis clinical trials
The registry lists 6 studies for Nephrosis across 2 countries. 0 are recruiting or about to start. 1 of them are mainly about Nephrosis (how this is decided). Per ClinicalTrials.gov, last updated 2022-11-15. Counting its 2 narrower conditions too, such as Nephrotic Syndrome: 239 studies, 86 open.
Who runs them
Goldfinch Bio, Inc. (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Seoul National University Hospital (1) · Daxor Corporation (1)
What is being tested here
Drugs under test in Nephrosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| GFB-887 | 0 | 0 | 3 |
| Mycophenolic Acid | 0 | 0 | 1 |
| Dexamethasone | 0 | 1 | 1 |
Who these studies take
No Nephrosis study is recruiting now.
Across all 6 studies, recruiting or not: 67% stop at 75 or younger and 33% at 65; 33% take children; 0% are for women only and 0% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. search them.
- A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change DiseaseTerminatedNCT04387448Phase 21 country
- An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney DiseasesTerminatedNCT04950114Phase 21 country
- FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy SubjectsCompletedNCT03970122Phase 11 country
- Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic SyndromeCompletedNCT01895894Phase 41 country
- Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume AnalyzerCompletedNCT01542749
- Steroid Treatment for Kidney DiseaseCompletedNCT00065611Phase 31 country